News & Updates

Show Multimedia Only
COVID-19 anticoagulation: How guidelines evolved amidst uncertainty
COVID-19 anticoagulation: How guidelines evolved amidst uncertainty
4 hours ago
ASCVD affects 1 in 6 adults with β-thalassaemia; etopivat shows promise
ASCVD affects 1 in 6 adults with β-thalassaemia; etopivat shows promise
04 Aug 2026 byElvira Manzano

Atherosclerotic cardiovascular disease (ASCVD) affects a substantial proportion of adults with β-thalassaemia. It appears to be driven by conventional CV risk factors rather than disease-specific features, according to research presented at EHA2026.

ASCVD affects 1 in 6 adults with β-thalassaemia; etopivat shows promise
04 Aug 2026
Is AF common among patients with migraine?
Is AF common among patients with migraine?
31 Jul 2026